Healthcare provider profile · identity verified

Nicole Davis, MD

Allopathic & Osteopathic Physicians|Family Medicine · WYNCOTE, PA · NPI 1275572901

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Nicole Davis, MD received $280.12 in general payments during 2025 across 8 reported records.

Novo Nordisk Inc accounted for 55.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$280.12

8 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$156.25	55.8%	6	2025
INTUITIVE SURGICAL, INC.	Unresolved — no canonical attribution shown	$106.11	37.9%	1	2025
Hologic Sales and Service, LLC	Unresolved — no canonical attribution shown	$17.76	6.3%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$280.12	8

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Da Vinci Surgical System Normalized: da vinci surgical system	Device	INTUITIVE SURGICAL, INC.	$106.11	1	2025
Source payment records 2025-06-10 · INTUITIVE SURGICAL, INC. · $106.11 · Open Payments source
APTIMA Normalized: aptima	Device	Hologic Sales and Service, LLC	$17.76	1	2025
Source payment records 2025-08-26 · Hologic Sales and Service, LLC · $17.76 · Open Payments source
THINPREP 2000 PROCESSOR Normalized: thinprep 2000 processor	Device	Hologic Sales and Service, LLC	$17.76	1	2025
Source payment records 2025-08-26 · Hologic Sales and Service, LLC · $17.76 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	776	158
Amlodipine Besylate	Amlodipine Besylate	432	95
Levothyroxine Sodium	Levothyroxine Sodium	377	44
Losartan Potassium	Losartan Potassium	291	68
Gabapentin	Gabapentin	271	37
Metoprolol Succinate	Metoprolol Succinate	265	40
Omeprazole	Omeprazole	229	32
Pantoprazole Sodium	Pantoprazole Sodium	224	36
Furosemide	Furosemide	200	30
Famotidine	Famotidine	199	29
Eliquis	Apixaban	191	24
Rosuvastatin Calcium	Rosuvastatin Calcium	186	34
Lisinopril	Lisinopril	179	34
Fluticasone Propionate	Fluticasone Propionate	171	50
Hydrochlorothiazide	Hydrochlorothiazide	171	48
Simvastatin	Simvastatin	152	31
Carvedilol	Carvedilol	141	25
Duloxetine Hcl	Duloxetine Hcl	137	15
Nifedipine Er	Nifedipine	135	29
Escitalopram Oxalate	Escitalopram Oxalate	128	16
Potassium Chloride	Potassium Chloride	118	21
Pravastatin Sodium	Pravastatin Sodium	114	33
Donepezil Hcl	Donepezil Hcl	101	15
Metformin Hcl Er	Metformin Hcl	96	27
Sertraline Hcl	Sertraline Hcl	95	suppressed
Allopurinol	Allopurinol	86	20
Montelukast Sodium	Montelukast Sodium	84	14
Atenolol	Atenolol	78	suppressed
Januvia	Sitagliptin Phosphate	78	15
Hydralazine Hcl	Hydralazine Hcl	75	11
Tramadol Hcl	Tramadol Hcl	72	23
Memantine Hcl	Memantine Hcl	69	suppressed
Metformin Hcl	Metformin Hcl	69	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	19
Valsartan	Valsartan	63	suppressed
Clopidogrel	Clopidogrel Bisulfate	62	13
Ezetimibe	Ezetimibe	61	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	suppressed
Spironolactone	Spironolactone	61	13
Mirtazapine	Mirtazapine	60	suppressed
Jardiance	Empagliflozin	58	11
Alendronate Sodium	Alendronate Sodium	56	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	56	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	54	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	53	suppressed
Methenamine Hippurate	Methenamine Hippurate	51	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	51	suppressed
Latanoprost	Latanoprost	49	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	47	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	43	suppressed
Trazodone Hcl	Trazodone Hcl	43	11
Finasteride	Finasteride	41	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	41	suppressed
Pregabalin	Pregabalin	41	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	suppressed
Nebivolol Hcl	Nebivolol Hcl	40	suppressed
Myrbetriq	Mirabegron	39	suppressed
Nyamyc	Nystatin	39	11
Tizanidine Hcl	Tizanidine Hcl	39	12
Triamcinolone Acetonide	Triamcinolone Acetonide	39	21
Xarelto	Rivaroxaban	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	suppressed
Ibuprofen	Ibuprofen	37	13
Meloxicam	Meloxicam	36	suppressed
Budesonide	Budesonide	35	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Torsemide	Torsemide	35	suppressed
Irbesartan	Irbesartan	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Glimepiride	Glimepiride	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	30	suppressed
Ranolazine Er	Ranolazine	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	29	suppressed
Prednisone	Prednisone	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Trimethoprim	Trimethoprim	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Ramipril	Ramipril	25	suppressed
Ursodiol	Ursodiol	25	suppressed
Acetylcysteine	Acetylcysteine	23	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	suppressed
Folic Acid	Folic Acid	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	22	suppressed
Erythromycin	Erythromycin Base	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Mometasone Furoate	Mometasone Furoate	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	21	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Tradjenta	Linagliptin	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	16
Propranolol Hcl	Propranolol Hcl	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Bupropion Hcl	Bupropion Hcl	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Cephalexin	Cephalexin	16	11
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Oxycontin	Oxycodone Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Prolia	Denosumab	15	suppressed
Risperidone	Risperidone	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	14	suppressed
Digoxin	Digoxin	13	suppressed
Enbrel Sureclick	Etanercept	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Linzess	Linaclotide	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Rhopressa	Netarsudil Mesylate	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Cardizem La	Diltiazem Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Nystatin	Nystatin	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$280.12 · 8 records	Novo Nordisk Inc	APTIMA, Da Vinci Surgical System, THINPREP 2000 PROCESSOR	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error